ViroPharma Announces Positive Phase 2 Results Demonstrating That Maribavir Significantly Reduces CMV Reactivation - Data Suggest That Maribavir May Alter Current CMV Prevention Strategies for Bone Marrow Transplant Patients - - Company to Host Conference Call to Discuss Clinical Results at 9:00 AM ET Tomorrow - <A HREF="http://phx.corporate-ir.net/phoenix.zhtml?c=92320&p=irol-newsArticle&ID=836796&highlight=" target="_blank">http://phx.corporate-ir.net/phoenix.zhtml?c=92320&p=irol-newsArticle&ID=836796&highlight...</A>